Business Standard

UK starts real-time review of Moderna's Covid-19 vaccine candidate

Moderna said earlier this month it was going to apply for real-time reviews of its experimental Covid-19 vaccine to Europe, following rolling reviews of shots of its rivals Pfizer Inc and AstraZeneca

moderna
Premium

Canada's health ministry is also in the process of reviewing Moderna's Covid-19 vaccine candidate in real time, the company said earlier this month.

Reuters
Moderna Inc said on Tuesday United Kingdom’s health regulator has started a real-time review of its experimental Covid-19 vaccine candidate.

The company has begun a rolling data submission from its vaccine candidate to UK’s Medicines and Healthcare products Regulatory Agency (MHRD) for it to start its independent assessment of evidence as and when it becomes available.

Such a process allows for a reduced time to approve a treatment, while maintaining the same standards of safety and effectiveness.

Moderna said earlier this month it was going to apply for real-time reviews of its experimental Covid-19 vaccine to Europe, following rolling reviews of shots of

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in